Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Product
6.1 Introduction
6.2 Cell-based products
6.2.1 Allogeneic products
6.2.2 Autologous products
6.3 Acellular products
Chapter 7 Market Segmentation by Application
7.1 Introduction
7.2 Orthopaedic and musculoskeletal disorders
7.3 Dermatology
7.4 Cardiology
7.5 Central nervous system diseases
7.6 Oncology
7.7 Diabetes
7.8 Bone graft substitutes
7.9 Others
Chapter 8 Market Segmentation by Therapy
8.1 Introduction
8.2 Cell therapy
8.3 Immunotherapy
8.4 Tissue therapy
8.5 Gene therapy
8.6 Others
Chapter 9 Market Segmentation by Material
9.1 Introduction
9.2 Algae-derived alginate
9.3 Synthetic polymer
9.4 Poly-lactide-coglycolide
9.5 Poly-ethylene glycol
9.6 Hydrogels
9.7 Others
Chapter 10 Market Segmentation by Agent type
10.1 Introduction
10.2 Biologics
10.2.1 Autologous fibroblasts
10.2.2 Hematopoietic stem and progenitor cells
10.3 Cell-based medical devices
10.3.1 Allogenic fibroblasts
10.3.2 Cell extraction
10.4 Biopharmaceuticals
10.4.1 Tricalcium phosphate
10.4.2 Osteogenic protein
Chapter 11 Market Segmentation by Geography
11.1 Asia-pacific
11.1.1 Introduction
11.1.2 China
11.1.3 Japan
11.1.4 India
11.1.5 Australia & New Zealand
11.1.6 Others
Chapter 12 Competitive Landscape
12.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
12.2 Market Share Analysis
12.3 Strategies Adopted By Top Companies
Chapter 13 Company Profiles
13.1 StemCells Inc.
13.1.1 Business Overview
13.1.2 Product portfolio
13.1.3 Key Strategy
13.1.4 Recent Developments
13.2 Mesoblast Ltd
13.3 Athersys Inc.
13.4 Neuralstem Inc.
13.5 Neo Stem Inc.
Chapter 14 Market Estimates and Forecast
14.1 Market Estimates and forecast 2018-2024(USD Billion)
14.1.1 Market Estimates and forecast by Product 2018-2024(USD Billion)
14.1.2 Market Estimates and forecast by Application 2018-2024(USD Billion)
14.1.3 Market Estimates and forecast by Therapy 2018-2024(USD Billion)
14.1.4 Market Estimates and forecast by Material 2018-2024(USD Billion)
14.1.5 Market Estimates and forecast by Agent type 2018-2024(USD Billion)
14.1.6 Market Estimates and forecast by geography 2018-2024(USD Billion)
Chapter 15 Market Insights
15.1 Insights of Industry Experts
15.2 Analyst Opinion (Market Understanding)
15.3 Investment Opportunities
Chapter 16 Appendix
16.1 List of Tables
16.2 List of Figures
